Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $76.99 in the prior trading day, Intra-Cellular Therapies Inc (NASDAQ: ITCI) closed at $75.69, down -1.69%. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 0.76 million shares were traded. ITCI stock price reached its highest trading level at $78.14 during the session, while it also had its lowest trading level at $74.9.
Ratios:
Our goal is to gain a better understanding of ITCI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.69 and its Current Ratio is at 7.81. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on January 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $83.
On December 11, 2023, TD Cowen started tracking the stock assigning a Outperform rating and target price of $75.
On April 20, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $80.Morgan Stanley initiated its Overweight rating on April 20, 2023, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 21 ’24 when Mates Sharon bought 53,013 shares for $75.59 per share.
Neumann Mark sold 18,714 shares of ITCI for $1,405,047 on Aug 16 ’24. The EVP, Chief Commercial Officer now owns 29,700 shares after completing the transaction at $75.08 per share. On Aug 16 ’24, another insider, Neumann Mark, who serves as the Officer of the company, bought 18,714 shares for $75.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITCI now has a Market Capitalization of 7997935616 and an Enterprise Value of 6993310720. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.17 while its Price-to-Book (P/B) ratio in mrq is 6.98. Its current Enterprise Value per Revenue stands at 12.388 whereas that against EBITDA is -62.466.
Stock Price History:
Over the past 52 weeks, ITCI has reached a high of $84.89, while it has fallen to a 52-week low of $45.50. The 50-Day Moving Average of the stock is 1.56%, while the 200-Day Moving Average is calculated to be 10.17%.
Shares Statistics:
The stock has traded on average 1.08M shares per day over the past 3-months and 542810 shares per day over the last 10 days, according to various share statistics. A total of 105.67M shares are outstanding, with a floating share count of 98.69M. Insiders hold about 6.60% of the company’s shares, while institutions hold 91.64% stake in the company. Shares short for ITCI as of 1722384000 were 2494903 with a Short Ratio of 2.31, compared to 1719532800 on 4135447. Therefore, it implies a Short% of Shares Outstanding of 2494903 and a Short% of Float of 2.71.
